Impact of statins and beta-blocker therapy on mortality after coronary artery bypass graft surgery.

Abstract

A post-discharge regimen of statins independently reduces overall and 1 year mortality. These results confirm those of earlier studies within a contemporary surgical population and support the current clinical guidelines.